JACC Basic to Translational Science · 2019 · 27 citations · 19 references
MedicineCardiologyPharmacologyDrug DeliveryInflammationMolecular PharmacologyCardiac PharmacotherapyCardiovascular PharmacodynamicsIschemic Heart DiseaseCardioprotective TherapyInfarct ExpansionInfarct Size AssessmentIschemic NecrosisMyocardial Ischemia-reperfusion InjuryNanoparticlesProangiogenic CytokinesProstacyclin Analogs
Intravenously injected ONO-1301-containing nanoparticles (ONO-1301NPs), unlike an ONO-1301 solution, selectively accumulated in the ischemia/reperfusion (I/R)-injured myocardium of rats and contributed to the prolonged retention of ONO-1301 in the targeted myocardial tissue. In the ischemic area, proangiogenic cytokines were up-regulated and inflammatory cytokines were down-regulated upon ONO-1301NP administration. Consequently, ONO-1301NP-injected rats exhibited a smaller infarct size, better-preserved capillary networks, and a better-preserved myocardial blood flow at 24 h after I/R injury, compared with those in vehicle-injected or ONO-1301 solution-injected rats. ONO-1301NPs attenuate the myocardial I/R injury via proangiogenic and anti-inflammatory effects of the drug.
19
Cyclosporine before PCI in Patients with Acute Myocardial Infarction
Thien-Tri Cung, Olivier Morel, Guillaume Cayla et al. · New England Journal of Medicine · 2015 · 680 citations · Full text
Allan M. Ross, Raymond J. Gibbons, Gregg W. Stone et al. · Journal of the American College of Cardiology · 2005 · 596 citations
Medicine, Cardiology, Pharmacology +13